Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 3
2014 4
2016 1
2017 1
2018 1
2019 2
2020 3
2021 3
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Heart-sparing radiotherapy techniques in breast cancer patients: a recommendation of the breast cancer expert panel of the German society of radiation oncology (DEGRO).
Duma MN, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Hehr T, Krug D, Piroth MD, Sedlmayer F, Souchon R, Sauer R; Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). Duma MN, et al. Strahlenther Onkol. 2019 Oct;195(10):861-871. doi: 10.1007/s00066-019-01495-w. Epub 2019 Jul 18. Strahlenther Onkol. 2019. PMID: 31321461 Review. English.
The data on the use of DIBH for heart-sparing in breast cancer patients is consistent and the benefit compared to free-breathing is supported by several studies. ...CONCLUSION: Based on the available findings, the DEGRO breast cancer expert panel recom …
The data on the use of DIBH for heart-sparing in breast cancer patients is consistent and the benefit compared to free-breathi …
DEGRO practical guideline for partial-breast irradiation.
Strnad V, Krug D, Sedlmayer F, Piroth MD, Budach W, Baumann R, Feyer P, Duma MN, Haase W, Harms W, Hehr T, Fietkau R, Dunst J, Sauer R; Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). Strnad V, et al. Strahlenther Onkol. 2020 Sep;196(9):749-763. doi: 10.1007/s00066-020-01613-z. Epub 2020 Apr 29. Strahlenther Onkol. 2020. PMID: 32350554 Free PMC article. Review.
PURPOSE: This consensus statement from the Breast Cancer Working Group of the German Society for Radiation Oncology (DEGRO) aims to define practical guidelines for accelerated partial-breast irradiation (APBI). ...
PURPOSE: This consensus statement from the Breast Cancer Working Group of the German Society for Radiation Oncology (DEGRO) ai …
DEGRO guideline for personalized radiotherapy of brain metastases and leptomeningeal carcinomatosis in patients with breast cancer.
Borm KJ, Behzadi ST, Hörner-Rieber J, Krug D, Baumann R, Corradini S, Duma MN, Dunst J, Fastner G, Feyer P, Fietkau R, Haase W, Harms W, Hehr T, Matuschek C, Piroth MD, Schmeel LC, Souchon R, Strnad V, Budach W, Combs SE; Breast Cancer Expert Panel of the German Society of Radiation Oncology DEGRO. Borm KJ, et al. Strahlenther Onkol. 2024 Apr;200(4):259-275. doi: 10.1007/s00066-024-02202-0. Epub 2024 Mar 15. Strahlenther Onkol. 2024. PMID: 38488902 Free PMC article. Review.
The search was performed using the following terms: (brain metastases OR leptomeningeal carcinomatosis) AND (breast cancer OR breast) AND (radiotherapy OR ablative radiotherapy OR radiosurgery OR stereotactic OR radiation). CONCLUSION AND RECOMMENDATIONS: Des …
The search was performed using the following terms: (brain metastases OR leptomeningeal carcinomatosis) AND (breast cancer OR …
Neoadjuvant chemotherapy for breast cancer-background for the indication of locoregional treatment.
Krug D, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Hehr T, Piroth MD, Sedlmayer F, Souchon R, Wenz F, Sauer R; Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). Krug D, et al. Strahlenther Onkol. 2018 Sep;194(9):797-805. doi: 10.1007/s00066-018-1329-8. Epub 2018 Jul 4. Strahlenther Onkol. 2018. PMID: 29974132 Review. English.
Neoadjuvant chemotherapy (NACT) has been widely adopted into the multidisciplinary management of breast cancer. The prognostic impact of treatment response has been clearly demonstrated. ...
Neoadjuvant chemotherapy (NACT) has been widely adopted into the multidisciplinary management of breast cancer. The prognostic …
Is the simultaneously integrated boost (SIB) technique for early breast cancer ready to be adopted for routine adjuvant radiotherapy? Statement of the German and the Austrian Societies of Radiooncology (DEGRO/OGRO).
Sedlmayer F, Sautter-Bihl ML, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Rödel C, Souchon R, Wenz F, Sauer R; Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). Sedlmayer F, et al. Strahlenther Onkol. 2013 Mar;189(3):193-6. doi: 10.1007/s00066-012-0300-3. Strahlenther Onkol. 2013. PMID: 23358687 No abstract available.
Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer : Statement from the DEGRO working group prostate cancer.
Ghadjar P, Aebersold DM, Albrecht C, Böhmer D, Flentje M, Ganswindt U, Höcht S, Hölscher T, Müller AC, Niehoff P, Pinkawa M, Sedlmayer F, Zips D, Wiegel T; Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and The Working Party Radiation Oncology of the German Cancer Society (DKG-ARO). Ghadjar P, et al. Strahlenther Onkol. 2020 Jul;196(7):589-597. doi: 10.1007/s00066-020-01598-9. Epub 2020 Mar 12. Strahlenther Onkol. 2020. PMID: 32166452 Free PMC article. Review.
AIM: To provide an overview on the available treatments to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer. METHODS: The German Society of Radiation Oncology (DEGRO) expert panel summarized available evidence pub …
AIM: To provide an overview on the available treatments to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen …
Current controversies in radiotherapy for breast cancer.
Krug D, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Piroth MD, Sautter-Bihl ML, Sedlmayer F, Souchon R, Wenz F, Sauer R; Breast cancer expert panel of the German Society of Radiation Oncology (DEGRO). Krug D, et al. Radiat Oncol. 2017 Jan 23;12(1):25. doi: 10.1186/s13014-017-0766-3. Radiat Oncol. 2017. PMID: 28114948 Free PMC article. Review.
Multimodal treatment approaches have substantially improved the outcome of breast cancer patients in the last decades. Radiotherapy is an integral component of multimodal treatment concepts used in curative and palliative intention in numerous clinical situations fr …
Multimodal treatment approaches have substantially improved the outcome of breast cancer patients in the last decades. Radioth …
Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward.
Krug D, Baumann R, Combs SE, Duma MN, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Hehr T, Piroth MD, Sedlmayer F, Souchon R, Strnad V, Budach W; Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). Krug D, et al. Strahlenther Onkol. 2021 Apr;197(4):269-280. doi: 10.1007/s00066-020-01744-3. Epub 2021 Jan 28. Strahlenther Onkol. 2021. PMID: 33507331 Free PMC article. Review.
Moderate hypofractionation is the standard of care for adjuvant whole-breast radiotherapy after breast-conserving surgery for breast cancer. Recently, 10-year results from the FAST and 5-year results from the FAST-Forward trial evaluating adjuvant whol …
Moderate hypofractionation is the standard of care for adjuvant whole-breast radiotherapy after breast-conserving surgery for …
DEGRO practical guidelines: radiotherapy of breast cancer III--radiotherapy of the lymphatic pathways.
Sautter-Bihl ML, Sedlmayer F, Budach W, Dunst J, Feyer P, Fietkau R, Fussl C, Haase W, Harms W, Piroth MD, Souchon R, Wenz F, Sauer R; Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). Sautter-Bihl ML, et al. Strahlenther Onkol. 2014 Apr;190(4):342-51. doi: 10.1007/s00066-013-0543-7. Epub 2014 Mar 5. Strahlenther Onkol. 2014. PMID: 24638236
AIM: The purpose of this work is to update the practical guidelines for adjuvant radiotherapy of the regional lymphatics of breast cancer published in 2008 by the breast cancer expert panel of the German Society of Radiation Oncology (DEGRO). ...Moreov …
AIM: The purpose of this work is to update the practical guidelines for adjuvant radiotherapy of the regional lymphatics of breast …
Radiotherapy after skin-sparing mastectomy with immediate breast reconstruction in intermediate-risk breast cancer : Indication and technical considerations.
Hehr T, Baumann R, Budach W, Duma MN, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Krug D, Piroth MD, Sedlmayer F, Souchon R, Wenz F, Sauer R; Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). Hehr T, et al. Strahlenther Onkol. 2019 Nov;195(11):949-963. doi: 10.1007/s00066-019-01507-9. Epub 2019 Aug 26. Strahlenther Onkol. 2019. PMID: 31451835 Review. English.
BACKGROUND: Skin-sparing (SSME) and nipple-sparing mastectomy (NSME) were developed to improve the cosmetic results for breast cancer (BC) patients, both allowing for immediate breast reconstruction. Recommendations for post-mastectomy radiotherapy (PMRT) are …
BACKGROUND: Skin-sparing (SSME) and nipple-sparing mastectomy (NSME) were developed to improve the cosmetic results for breast can …
18 results